Cleared Abbreviated

K162960 - TotalC-Ram

K162960 is an FDA 510(k) clearance for TotalC-Ram, manufactured by Itena Clinical. The device is a Class 2 Dental device with product code EMA cleared through the Abbreviated 510(k) pathway after a 141-day FDA review.

K162960 · Itena Clinical · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2017
Decision
141d
Days
Class 2
Risk

K162960 is an FDA 510(k) clearance for the TotalC-Ram. Classified as Cement, Dental (product code EMA), Class II - Special Controls.

Submitted by Itena Clinical (Paris, FR). The FDA issued a Cleared decision on March 14, 2017 after a review of 141 days - within the typical 510(k) review window.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3275 - the FDA dental device regulatory framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Itena Clinical devices

FDA 510(k) Submission Details - K162960

510(k) Number K162960 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 24, 2016
Decision Date March 14, 2017
Days to Decision 141 days
Submission Type Abbreviated
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
14d slower than avg
Panel avg: 127d · This submission: 141d
Pathway characteristics
Standards-based clearance path.

EMA Device Classification - Class 2, Special Controls

Product Code EMA Cement, Dental
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3275
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.